Immunopathological Study Of Expressions P53 And PCNA In Oral Premalignant Lesions

Amani Nour El Din Abd Ellatif;

Abstract


Oral cancer is the sixth most common cancer in the world. Despite advances in its treatment, no significant prognosis has been observed. If prognosis 1s to be improved, then the disease has to be diagnosed at an
early stage.



Some squamous cell carcmomas of the head and neck arise from premalignant lesions such as leukoplakia, papilloma and others. It is important to assess with accuracy and at early stage the likelihood of malignant development of these premalignant lesions. Therefore, there is an important need to identify potential biomarkers of tumorigenesis that can be utilized on premalignant lesions to determine the level of risk for
tumor development.



The biomarker p53 was successfully used as a biomarker for oral squamous cell carcinoma, but three were not enough reports to determine the risk of tumorigenesity of oral premalignant lesions and to compare p53 antibody with PCNA antibody.


The purpose of the study was to find out whether detection of p53 expression in premalignant oral lesions will help identifying lesions that are at higher risk of progressing to malignancy and to find out PCNA


Other data

Title Immunopathological Study Of Expressions P53 And PCNA In Oral Premalignant Lesions
Other Titles دراسة مناعية باثولوجية لوجود P53 و PCNA في الإصابات الفموية ما قبل السرطانية
Authors Amani Nour El Din Abd Ellatif
Issue Date 1999

Attached Files

File SizeFormat
ص3979.pdf1.48 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 3 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.